200 related articles for article (PubMed ID: 17196702)
1. Impurities in generic pharmaceutical development.
Kovaleski J; Kraut B; Mattiuz A; Giangiulio M; Brobst G; Cagno W; Kulkarni P; Rauch T
Adv Drug Deliv Rev; 2007 Jan; 59(1):56-63. PubMed ID: 17196702
[TBL] [Abstract][Full Text] [Related]
2. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in generic drug product development.
Snider DA; Addicks W; Owens W
Adv Drug Deliv Rev; 2004 Feb; 56(3):391-5. PubMed ID: 14962588
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane.
Taylor PW; Keenan MH
Curr Med Res Opin; 2006 Mar; 22(3):603-15. PubMed ID: 16574043
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical impurities: regulatory perspective for Abbreviated New Drug Applications.
Basak AK; Raw AS; Al Hakim AH; Furness S; Samaan NI; Gill DS; Patel HB; Powers RF; Yu L
Adv Drug Deliv Rev; 2007 Jan; 59(1):64-72. PubMed ID: 17196703
[TBL] [Abstract][Full Text] [Related]
6. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
Carrillo Norte JA; Postigo Mota S
Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
[TBL] [Abstract][Full Text] [Related]
7. Current approaches to the use of generic antiepileptic drugs.
Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
[TBL] [Abstract][Full Text] [Related]
8. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
[TBL] [Abstract][Full Text] [Related]
9. Analysis of purity profiles of generic lisinopril tablets marketed in Croatia.
Benković G; Sokolić M; Cudina B; Zulj RT; Tomić S
Coll Antropol; 2013 Jun; 37(2):601-6. PubMed ID: 23941010
[TBL] [Abstract][Full Text] [Related]
10. [Generics: similarities, bioequivalence but no conformity].
Even-Adin D; De Muylder JA; Sternon J
J Pharm Belg; 2002; 57(1):14-20. PubMed ID: 11913095
[TBL] [Abstract][Full Text] [Related]
11. [Generics: essentially similar, bioequivalent but not identical].
Even-Adin D; De Muylder JA; Sternon J
Rev Med Brux; 2001 Dec; 22(6):513-20. PubMed ID: 11811047
[TBL] [Abstract][Full Text] [Related]
12. [Generics: authorization to market and quality guarantees].
De Muylder JA
Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
[TBL] [Abstract][Full Text] [Related]
13. The importance of brand continuity in epilepsy drugs.
Goodwin M
Nurs Times; 2005 Jun 21-27; 101(25):26-7. PubMed ID: 15997944
[TBL] [Abstract][Full Text] [Related]
14. [Sevoflurane and propofol: original and generic].
Al-Nasser B
Ann Fr Anesth Reanim; 2008 Jan; 27(1):120-2. PubMed ID: 18191934
[No Abstract] [Full Text] [Related]
15. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
Tsai YS; Lan SK; Ou JH; Tzai TS
Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
[TBL] [Abstract][Full Text] [Related]
16. Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reporting.
Lamarque V; Merle L; Demarez JP;
Therapie; 2008; 63(4):301-9. PubMed ID: 18937910
[TBL] [Abstract][Full Text] [Related]
17. Are generic and brand name drugs different in terms of quality?
Johns Hopkins Med Lett Health After 50; 2000 Feb; 11(12):8. PubMed ID: 10732507
[No Abstract] [Full Text] [Related]
18. [Generic drugs in psychopharmacology: pros and cons].
Cuenca E; Zaragozá F
Actas Esp Psiquiatr; 1999; 27(6):351-7. PubMed ID: 10611558
[TBL] [Abstract][Full Text] [Related]
19. [Bioequivalence studies of pharmaceutical preparations].
Vetchý D; Frýbortová K; Rabisková M; Danecková H
Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
[TBL] [Abstract][Full Text] [Related]
20. Generic medications: another variable in the treatment of illnesses.
Blier P
J Psychopharmacol; 2007 Jul; 21(5):459-60. PubMed ID: 17664245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
